Filing status
- Last accounts
- 31 December 2024
- Last conf. stmt
- 1 March 2025
Morphic Therapeutic UK Ltd
- Incorporated
- 2 March 2022
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Christopher Stokes
- Owned by
- Morphic Therapeutic, Inc.
- Accounts type
- Small
- Region
- South East
- Address
- Lilly HouseBasingviewBasingstokeRG21 4FA
Officers 2 on record
Officer details are public data from the Companies House register.
Director · Appointed 8 August 2025
American
Born November 1978
Stokes, Christopher
Director · Appointed 5 November 2024
American
Born January 1979 (47)
Officer history (6 former)
8 August 2025
Resigned Nonaka, Yuya as Director
8 August 2025
5 November 2024
Resigned Farrell, Robert as Director
5 November 2024
Appointed Nonaka, Yuya as Director
5 November 2024
Resigned Devaul, William as Secretary
5 November 2024
Resigned Devaul, William as Director
5 November 2024
Appointed Stokes, Christopher as Director
5 November 2024
Resigned Schegerin, Marc as Director
5 November 2024
Resigned Tipirneni, Praveen as Director
2 March 2022
Appointed Devaul, William as Secretary
2 March 2022
Appointed Devaul, William as Director
2 March 2022
Appointed Farrell, Robert as Director
2 March 2022
Appointed Schegerin, Marc as Director
2 March 2022
Appointed Tipirneni, Praveen as Director
Ownership 1 on record
People and entities with significant control, from the Companies House PSC register
Morphic Therapeutic, Inc.
Corporate entity · Notified 2 March 2022
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Public Company
Filings
Filing history not loaded yet. See it on Companies House
Other companies in this industry
By trade and location
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →